Otsuka Pharmaceutical Development & Commercialization, Inc.
Overview
Otsuka Pharmaceutical Development & Commercialization, Inc. is a subsidiary of Otsuka Pharmaceutical Co., Ltd., focused on the development, clinical research, and commercialization of pharmaceutical products. The company is known for its innovative therapies in the mental health and kidney disease domains.
Therapeutic areas
FDA compliance signals
4 FDA enforcement records linked to this company.
- recall — Class III2018-10-10
Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
- recall — Class III2018-10-10
Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
- 4832014-03-18
Late submission of 15-day report
- 4832014-03-18
Submission of report follow-up
Is this Otsuka Pharmaceutical Development & Commercialization, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.